相关实验视频

Updated: Jun 3, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

慢性手湿疹皮肤的转录形状分析揭示了跨亚型的共享免疫路径和分子驱动因素

Anna Sophie Quaade¹, Thomas Litman², Xing Wang³

¹The National Allergy Research Centre, Department of Dermatology and Allergy, Copenhagen University Hospital, Herlev-Gentofte, Hellerup, Denmark.

The Journal of allergy and clinical immunology

|January 10, 2025

概括

慢性手湿疹 (CHE) 转录组显示在亚型中共享免疫通路激活. 确定了关键的调节因素,这表明了这种常见的皮肤疾病的潜在普遍治疗点.

科学领域:

皮肤病学皮肤病学
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

慢性手湿疹 (CHE) 是一种流行性皮肤疾病,具有多种亚型.
对于区分这些CHE亚型的分子特征的理解有限.

研究的目的:

为了全面描述慢性手湿疹的转录组,跨其各种亚型.
在CHE中识别分子模式和潜在的治疗点.

主要方法:

在CHE患者和健康对照患者的220个皮肤活检样本上使用RNA测序.
分析的重点是受损的CHE手掌样本,按亚托皮性皮炎 (AD) 状态和病因分层.
通过使用英才途径分析 (IPA) 进行了差异表达基因 (DEG) 和途径分析.

主要成果:

在健康的手掌皮肤和受CHE影响的手掌皮肤之间观察到显著的转录组变异.
在CHE手掌中发现了2333个DEG,其中上调的基因与炎症相关,下调的基因与屏障功能相关.
促炎途径 (T_H1,T_H2) 被激活,其中关键调节者包括IFN-γ,TNF,IL-4和IL-1β.

结论:

损伤的CHE转录组在各个亚型中大致保持不变,以T_H1和T_H2免疫通路激活为标志.
确定了共享的上游监管机构,表明了CHE的潜在普遍治疗目标.
在健康的皮肤和受影响的皮肤上都注意到了解剖学部位特定的转录组差异.

关键词:

过敏接触性皮肤炎过敏接触性皮肤炎有关RNA测序的RNA测序亚托邦性皮肤炎的发生.生物标志物生物标志物接触过敏接触过敏接触性皮肤炎的情况手上的湿疹手湿疹.翻译学翻译学翻译学翻译学

更多相关视频

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation

Published on: March 8, 2024

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...